The normal endothelium exerts an important protective influence on the vessel wall by producing the potent vasodilator factor, nitric oxide, which also inhibits platelet deposition and smooth muscle cell proliferation. Evidence indicating that hyperlipidemia can compromize the release or action of endothelium-derived nitric oxide is reviewed. Also, lipid disorders may induce the production by endothelium of vasoconstrictor and mitogenic factors, including endothelin-1, and the prothrombotic factor, plasminogen activator inhibitor-1. Together, these abnormalities in endothelial cell synthetic function caused by hyperlipidemias may contribute to the development and clinical manifestations of atherosclerotic vascular disease.